Literature DB >> 13998253

Per cent absorbed time plots derived from blood level and/or urinary excretion data.

J G WAGNER, E NELSON.   

Abstract

Keywords:  BLOOD CHEMICAL ANALYSIS; METABOLISM; URINE

Mesh：

Year:  1963        PMID： 13998253     DOI： 10.1002/jps.2600520629

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN： 0022-3549            Impact factor:   3.534


× No keyword cloud information.
  84 in total

1.  The rate and extent of oral bioavailability versus the rate and extent of oral absorption: clarification and recommendation of terminology.

Authors:  W L Chiou
Journal:  J Pharmacokinet Pharmacodyn       Date:  2001-02       Impact factor: 2.745

2.  Do you need a pharmacokinetic model, and, if so, which one?

Authors:  J G Wagner
Journal:  J Pharmacokinet Biopharm       Date:  1975-12

3.  Biopharmaceutical characterisation of a low-dose (75 mg) controlled-release aspirin formulation.

Authors:  W N Charman; S A Charman; D C Monkhouse; S E Frisbee; E A Lockhart; S Weisman; G A Fitzgerald
Journal:  Br J Clin Pharmacol       Date:  1993-11       Impact factor: 4.335

4.  In vitro-in vivo correlations: tricks and traps.

Authors:  J-M Cardot; B M Davit
Journal:  AAPS J       Date:  2012-05-01       Impact factor: 4.009

5.  Bioavailability of commercial tetracycline products.

Authors:  D B Barnett; R N Smith; N D Greenwood; C Hetherington
Journal:  Br J Clin Pharmacol       Date:  1974-08       Impact factor: 4.335

Review 6.  Pharmacokinetic characterization of controlled-release formulations.

Authors:  V W Steinijans
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1990 Apr-Jun       Impact factor: 2.441

7.  Linear pharmacokinetic models and vanishing exponential terms: implications in pharmacokinetics.

Authors:  J G Wagner
Journal:  J Pharmacokinet Biopharm       Date:  1976-10

8.  Pharmacokinetics of carbamazepine in normal humans after single and repeated oral doses.

Authors:  A P Géradin; F V Abadie; J A Campestrini; W Theobald
Journal:  J Pharmacokinet Biopharm       Date:  1976-12

Review 9.  Novel drug delivery systems. An overview of their impact on clinical pharmacokinetic studies.

Authors:  P S Banerjee; J R Robinson
Journal:  Clin Pharmacokinet       Date:  1991-01       Impact factor: 6.447

Review 10.  Theophylline. Pooled Michaelis-Menten parameters (Vmax and Km) and implications.

Authors:  J G Wagner
Journal:  Clin Pharmacokinet       Date:  1985 Sep-Oct       Impact factor: 6.447
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.